Free Trial

Wolverine Asset Management LLC Has $3.03 Million Stock Holdings in Medical Properties Trust, Inc. (NYSE:MPW)

Medical Properties Trust logo with Finance background

Wolverine Asset Management LLC lifted its stake in Medical Properties Trust, Inc. (NYSE:MPW - Free Report) by 27.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 517,866 shares of the real estate investment trust's stock after acquiring an additional 112,721 shares during the quarter. Wolverine Asset Management LLC owned approximately 0.09% of Medical Properties Trust worth $3,030,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of MPW. CWA Asset Management Group LLC purchased a new position in Medical Properties Trust during the third quarter worth $878,000. Sittner & Nelson LLC acquired a new position in shares of Medical Properties Trust in the 3rd quarter worth approximately $234,000. Jmac Enterprises LLC purchased a new position in shares of Medical Properties Trust in the third quarter worth approximately $70,000. KG&L Capital Management LLC increased its position in Medical Properties Trust by 5.3% during the third quarter. KG&L Capital Management LLC now owns 50,875 shares of the real estate investment trust's stock worth $298,000 after acquiring an additional 2,550 shares during the period. Finally, Van ECK Associates Corp increased its stake in shares of Medical Properties Trust by 12.3% in the 3rd quarter. Van ECK Associates Corp now owns 251,959 shares of the real estate investment trust's stock valued at $1,474,000 after acquiring an additional 27,597 shares during the last quarter. Institutional investors and hedge funds own 71.79% of the company's stock.

Insider Buying and Selling at Medical Properties Trust

In other Medical Properties Trust news, Director Elizabeth N. Pitman acquired 8,087 shares of the business's stock in a transaction that occurred on Wednesday, September 18th. The stock was acquired at an average price of $6.01 per share, with a total value of $48,602.87. Following the transaction, the director now owns 76,740 shares of the company's stock, valued at approximately $461,207.40. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director C Reynolds Thompson III sold 20,530 shares of Medical Properties Trust stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total transaction of $89,921.40. Following the completion of the transaction, the director now owns 54,637 shares of the company's stock, valued at $239,310.06. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Elizabeth N. Pitman bought 8,087 shares of Medical Properties Trust stock in a transaction dated Wednesday, September 18th. The shares were bought at an average cost of $6.01 per share, with a total value of $48,602.87. Following the completion of the acquisition, the director now owns 76,740 shares of the company's stock, valued at $461,207.40. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 63,335 shares of company stock valued at $318,825 in the last three months. 1.53% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts have commented on MPW shares. Colliers Securities upgraded Medical Properties Trust from a "neutral" rating to a "buy" rating and set a $6.50 target price for the company in a research note on Friday, September 13th. Truist Financial upped their price target on shares of Medical Properties Trust from $5.00 to $6.00 and gave the stock a "hold" rating in a research report on Friday, September 13th. Finally, Wolfe Research upgraded shares of Medical Properties Trust to a "hold" rating in a research report on Monday, September 23rd. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, Medical Properties Trust currently has a consensus rating of "Hold" and an average target price of $5.50.

Check Out Our Latest Research Report on Medical Properties Trust

Medical Properties Trust Stock Performance

MPW traded down $0.18 during midday trading on Tuesday, hitting $4.35. 12,467,073 shares of the company traded hands, compared to its average volume of 16,934,117. The company has a quick ratio of 2.93, a current ratio of 2.38 and a debt-to-equity ratio of 1.69. The firm has a market capitalization of $2.61 billion, a PE ratio of -1.07, a price-to-earnings-growth ratio of 0.72 and a beta of 1.32. The company's 50-day moving average is $5.17 and its 200 day moving average is $4.93. Medical Properties Trust, Inc. has a 52 week low of $2.92 and a 52 week high of $6.55.

Medical Properties Trust Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 10th. Stockholders of record on Monday, September 9th were paid a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a dividend yield of 7.36%. The ex-dividend date was Monday, September 9th. Medical Properties Trust's payout ratio is -7.58%.

Medical Properties Trust Profile

(Free Report)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

Featured Stories

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Should you invest $1,000 in Medical Properties Trust right now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines